Bionomics Statistics
Total Valuation
Bionomics has a market cap or net worth of $10.26 million. The enterprise value is $1.69 million.
| Market Cap | 10.26M |
| Enterprise Value | 1.69M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Bionomics has 10.69 million shares outstanding. The number of shares has increased by 14.43% in one year.
| Shares Outstanding | 10.69M |
| Shares Change (YoY) | +14.43% |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 21.67% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.03.
| PE Ratio | 0.03 |
| Forward PE | n/a |
| PS Ratio | 683.83 |
| Forward PS | n/a |
| PB Ratio | 0.55 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 112.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.81 |
| Quick Ratio | 3.47 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -978.98 |
Financial Efficiency
Return on equity (ROE) is -80.80% and return on invested capital (ROIC) is -0.74%.
| Return on Equity (ROE) | -80.80% |
| Return on Assets (ROA) | -65.20% |
| Return on Capital (ROIC) | -0.74% |
| Revenue Per Employee | $1,875 |
| Profits Per Employee | -$2.64M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Bionomics has paid $2,420 in taxes.
| Income Tax | 2,420 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.37% in the last 52 weeks. The beta is -0.09, so Bionomics's price volatility has been lower than the market average.
| Beta (1Y) | -0.09 |
| 52-Week Price Change | -57.37% |
| 50-Day Moving Average | 1.08 |
| 200-Day Moving Average | 1.72 |
| Relative Strength Index (RSI) | 38.41 |
| Average Volume (30 Days) | 186,669 |
Short Selling Information
The latest short interest is 258,390, so 2.42% of the outstanding shares have been sold short.
| Short Interest | 258,390 |
| Short Previous Month | 58,182 |
| Short % of Shares Out | 2.42% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.40 |
Income Statement
In the last 12 months, Bionomics had revenue of $14,998 and -$21.09 million in losses.
| Revenue | 14,998 |
| Gross Profit | 14,206 |
| Operating Income | -144,963 |
| Pretax Income | -19.98M |
| Net Income | -21.09M |
| EBITDA | n/a |
| EBIT | -19.96M |
| Earnings Per Share (EPS) | $32.24 |
Balance Sheet
The company has $9.58 million in cash and $1.01 million in debt, giving a net cash position of $8.57 million or $0.80 per share.
| Cash & Cash Equivalents | 9.58M |
| Total Debt | 1.01M |
| Net Cash | 8.57M |
| Net Cash Per Share | $0.80 |
| Equity / Book Value | 18.71M |
| Book Value Per Share | 1.75 |
| Working Capital | 8.01M |
Cash Flow
| Operating Cash Flow | -17.17M |
| Capital Expenditures | n/a |
| Free Cash Flow | -17.17M |
| FCF Per Share | -$2.08 |
Margins
Gross margin is 94.72%, with operating and profit margins of -966.55% and -140,642.11%.
| Gross Margin | 94.72% |
| Operating Margin | -966.55% |
| Pretax Margin | -133,203.37% |
| Profit Margin | -140,642.11% |
| EBITDA Margin | n/a |
| EBIT Margin | -133,067.45% |
| FCF Margin | -114,460.46% |
Dividends & Yields
Bionomics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.43% |
| Shareholder Yield | -14.43% |
| Earnings Yield | -205.67% |
| FCF Yield | -167.38% |
Analyst Forecast
The average price target for Bionomics is $9.00, which is 838.38% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 838.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bionomics has an Altman Z-Score of -9.15 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.15 |
| Piotroski F-Score | 2 |